Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab Top-Down vs Step-Up in Pediatric Crohn's Disease
NCT01752790Phase 4Withdrawn
- Sponsor
- Sapienza University of Rome
- Start
- Dec 2012
- Primary completion
- Jan 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of infliximab in Crohn's disease, sponsored by Sapienza University of Rome. Planned start Dec 2012; status: withdrawn.
02
Drugs
infliximab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT01752790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01752790.